Apparent Diffusion Coefficient Value can Predict Poor Bacillus Calmette–Guérin Responders in T1HG/NMIBC: Prospective Cohort Study
- 12 March 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 19 (4), e248-e254
- https://doi.org/10.1016/j.clgc.2021.03.001
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular MarkersEuropean Urology, 2012
- Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-αJournal of Urology, 2011
- Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?European Urology, 2008
- Intravesical Pharmacotherapy for Non–Muscle-Invasive Bladder Cancer: A Critical Analysis of Currently Available Drugs, Treatment Schedules, and Long-Term ResultsEuropean Urology, 2008
- Long-Term Follow-up of Patients with Stage T1 High-Grade Transitional Cell Carcinoma Managed by Bacille Calmette-Guérin ImmunotherapyUrology, 2007
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Diffusion-weighted magnetic resonance imaging and its application to cancerCancer Imaging, 2006
- A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and SurvivalJournal of Urology, 2003
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Diffusion imaging using stimulated echoesMagnetic Resonance in Medicine, 1991